{"product_id":"9780792387961","title":"Falk Symposium: An Update on SNMC (Stronger Neo-Minophagen C). In honour of Hans Popper's 100th birthday","description":"\u003ch1\u003eFalk Symposium: An Update on SNMC (Stronger Neo-Minophagen C). In honour of Hans Popper's 100th birthday\u003c\/h1\u003e \u003ch2\u003eHiyashi, N.; Manns, M.P.\u003c\/h2\u003e \u003cp\u003e\u003c\/p\u003e\u003cp\u003eIn several liver diseases, the underlying cause cannot always be eliminated, i.e. the progression of liver disease cannot be prevented. This is particularly true for non-responders to the treatment of chronic hepatitis C (HCV). It is relevant for more than 40% of patients with HCV genotype 1 and up to 20% of patients with genotype 2 or 3. Several approaches are now underway to prevent or ameliorate mechanisms of disease progression. In Asia, and particularly in Japan, Glycyrrhizine-SNMC has been widely used for this purpose. At present, SNMC is under clinical evaluation in Europe. \u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e \u003ch3\u003eDetails\u003c\/h3\u003e \u003cp\u003ePublished by: Springer\u003c\/p\u003e \u003cp\u003ePublication Date: 2004-07-21\u003c\/p\u003e \u003cp\u003eFormat: Hardcover\u003c\/p\u003e \u003cp\u003eISBN-13: 9780792387961\u003c\/p\u003e \u003cp\u003eDOI: \u003c\/p\u003e \u003cp\u003eDimensions: 235cm x155cm\u003c\/p\u003e \u003cp\u003ePages: 130\u003c\/p\u003e ","brand":"Springer Netherlands","offers":[{"title":"Default Title","offer_id":44541623009420,"sku":"9780792387961","price":98.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0710\/9545\/1788\/files\/9780792387961.jpg?v=1770783637","url":"https:\/\/lateknightbooks.com\/products\/9780792387961","provider":"Late Knight Books and Services, LLC","version":"1.0","type":"link"}